17 Pembroke Street Upper
D02 AT22
Dublin 2
Ireland
353 1 661 9819
https://ovocabio.com
Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 5
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. Kirill Andreyevich Golovanov | Interim Chairman of the Board & CEO | 125,66k | N/A | 1978 |
Mr. Dmitriy Nikitashenko | Vice President of Finance | N/A | N/A | N/A |
Reneta Nikolova | Corporate Secretary | N/A | N/A | N/A |
Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for women health. It is developing BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.
Ovoca Bio plcs ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.